Contenders Emerge for FDA Commissioner Role Amid Heart Drug Setback
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Lifestyle trends and health tips
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contributions remain overshadowed by political figures.
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of American workers and their families.
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that could have global repercussions.
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospitals while benefiting for-profits.
Elevance Health has initiated legal action against the U.S. government, claiming improper recalculation of its Medicare Advantage ratings that jeopardize $115 million in funding.
Roche's new KRAS-targeted therapy is poised to redefine lung cancer treatment, showing impressive efficacy and safety in clinical trials.
Frequent and severe heat waves are significantly impacting public health, with rising temperatures posing increased risks to Americans' wellbeing.
UpDoc's FDA-cleared app integrates large language models to assist diabetes management, sparking conversations about AI's role in patient care.
Experts suggest reintroducing the presidential fitness test is a positive move but insufficient alone to address childhood inactivity.
A recent study highlights that older adults with obesity are achieving better cardiovascular health metrics, potentially due to increased use of statins and blood pressure drugs.
Multiplet, an engaging daily puzzle game, redefines chemistry learning with fun challenges that rival popular word games.
A team has created potential synthetic cells, sparking debate over their life-like properties and implications for biological engineering.
Anthropic launches Claude Science to aid pharmaceutical research, while Trump's drug pricing plans face hurdles with mid-sized companies.
Zyn's nicotine pouch marketing is approved by the FDA, claiming lower risks compared to cigarettes, prompting concern among health advocates.
A recent revelation exposes the alcohol industry's significant financial influence on public health organizations, impacting cancer prevention messaging.